BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34564402)

  • 21. Metabolomic Status of The Oral Cavity in Chronic Periodontitis.
    Gawron K; Wojtowicz W; Łazarz-Bartyzel K; Łamasz A; Qasem B; Mydel P; Chomyszyn-Gajewska M; Potempa J; Mlynarz P
    In Vivo; 2019; 33(4):1165-1174. PubMed ID: 31280206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saliva: a fluid of study for OMICS.
    Cuevas-Córdoba B; Santiago-García J
    OMICS; 2014 Feb; 18(2):87-97. PubMed ID: 24404837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Saliva of patients affected by salivary gland tumour: An NMR metabolomics analysis.
    Grimaldi M; Palisi A; Rossi G; Stillitano I; Faiella F; Montoro P; Rodriquez M; Palladino R; Maria D'Ursi A; Romano R
    J Pharm Biomed Anal; 2018 Oct; 160():436-442. PubMed ID: 30138814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salivary proteomics: A new adjuvant approach to the early diagnosis of familial juvenile systemic lupus erythematosus.
    Abrão AL; Falcao DP; de Amorim RF; Bezerra AC; Pombeiro GA; Guimarães LJ; Fregni F; Silva LP; da Mota LM
    Med Hypotheses; 2016 Apr; 89():97-100. PubMed ID: 26968919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
    Sridharan G; Ramani P; Patankar S; Vijayaraghavan R
    J Oral Pathol Med; 2019 Apr; 48(4):299-306. PubMed ID: 30714209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Saliva Metabolome in Association to Oral Health Status.
    Liebsch C; Pitchika V; Pink C; Samietz S; Kastenmüller G; Artati A; Suhre K; Adamski J; Nauck M; Völzke H; Friedrich N; Kocher T; Holtfreter B; Pietzner M
    J Dent Res; 2019 Jun; 98(6):642-651. PubMed ID: 31026179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Finding distinctions between oral cancer and periodontitis using saliva metabolites and machine learning.
    Kouznetsova VL; Li J; Romm E; Tsigelny IF
    Oral Dis; 2021 Apr; 27(3):484-493. PubMed ID: 32762095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic approach to thyroid cancer based on amino acid metabolomics in saliva by ultra-performance liquid chromatography with high resolution mass spectrometry.
    Zhang J; Wen X; Li Y; Zhang J; Li X; Qian C; Tian Y; Ling R; Duan Y
    Talanta; 2021 Dec; 235():122729. PubMed ID: 34517597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Periodontal Inflammation via Metabolic Profiling of Saliva.
    Kuboniwa M; Sakanaka A; Hashino E; Bamba T; Fukusaki E; Amano A
    J Dent Res; 2016 Nov; 95(12):1381-1386. PubMed ID: 27470067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of salivary phenotypes of generalized aggressive and chronic periodontitis through nuclear magnetic resonance-based metabolomics.
    Romano F; Meoni G; Manavella V; Baima G; Tenori L; Cacciatore S; Aimetti M
    J Periodontol; 2018 Dec; 89(12):1452-1460. PubMed ID: 29877582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of masticatory stimulation on the quantity and quality of saliva and the salivary metabolomic profile.
    Okuma N; Saita M; Hoshi N; Soga T; Tomita M; Sugimoto M; Kimoto K
    PLoS One; 2017; 12(8):e0183109. PubMed ID: 28813487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection.
    Ishikawa S; Sugimoto M; Kitabatake K; Tu M; Sugano A; Yamamori I; Iba A; Yusa K; Kaneko M; Ota S; Hiwatari K; Enomoto A; Masaru T; Iino M
    Amino Acids; 2017 Apr; 49(4):761-770. PubMed ID: 28101653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
    Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
    Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saliva in the "Omics" era: A promising tool in paediatrics.
    Pappa E; Kousvelari E; Vastardis H
    Oral Dis; 2019 Jan; 25(1):16-25. PubMed ID: 29750386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the origin and diagnostic use of salivary RNA.
    Fábryová H; Celec P
    Oral Dis; 2014 Mar; 20(2):146-52. PubMed ID: 23517132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolomics study of oral cancers.
    Chen X; Yu D
    Metabolomics; 2019 Feb; 15(2):22. PubMed ID: 30830419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatially resolved sampling for untargeted metabolomics: A new tool for salivomics.
    Ciurli A; Liebl M; Derks RJE; Neefjes JJC; Giera M
    iScience; 2021 Jul; 24(7):102768. PubMed ID: 34278270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in salivary protein glycosylation and its relationship with systemic and oral diseases].
    Ma R; Peng X; Xu Y; Duan DY
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Jun; 36(3):336-341. PubMed ID: 29984939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New Approach for the Diagnosis of Systemic and Oral Diseases Based on Salivary Biomolecules.
    Roi A; Rusu LC; Roi CI; Luca RE; Boia S; Munteanu RI
    Dis Markers; 2019; 2019():8761860. PubMed ID: 30906485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.